- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Nilogen Oncosystems
Total 710 results
-
BiogenAcorda TherapeuticsCompleted
-
BiogenCrescendo BiosciencesCompletedArthritis, RheumatoidUnited States
-
BiogenElan PharmaceuticalsCompleted
-
Facet BiotechBiogenTerminatedPeritoneal Neoplasms | Ovarian CancerUnited States, Canada
-
Uni-PharmaBiogenCompletedChronic Plaque Psoriasis
-
Philogen S.p.A.Boehringer IngelheimCompletedAcute Myeloid Leukemia (AML) RelapseGermany
-
Philogen S.p.A.Eudax S.r.l.Completed
-
Reata, a wholly owned subsidiary of BiogenRecruitingA Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS) (CYPRESS)Diabetic Peripheral Neuropathic PainUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedHepatic ImpairmentUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenWithdrawnDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenTerminatedLiver DiseaseUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenWithdrawnDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy | Hepatic ImpairmentUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedOcular Inflammation | Ocular Pain | Corneal Endothelial Cell Loss | Cataract SurgeryUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedInflammation and Pain Following Ocular SurgeryUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMItochondrial MyopathiesUnited States, Denmark
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompleted
-
Sage TherapeuticsBiogenActive, not recruiting
-
Sage TherapeuticsBiogenCompletedMajor Depressive DisorderUnited States
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States, Puerto Rico
-
Eisai Inc.BiogenActive, not recruitingEarly Alzheimer's DiseaseUnited States, Spain, Korea, Republic of, China, United Kingdom, Australia, Canada, France, Germany, Italy, Japan, Russian Federation, Singapore, Sweden
-
Knopp BiosciencesBiogenTerminatedAmyotrophic Lateral SclerosisUnited States, United Kingdom, Netherlands, Spain, Belgium, Germany, Australia, Sweden, France, Ireland, Canada
-
Eisai Inc.BiogenTerminated
-
BiogenYale UniversityCompleted
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
Quintiles, Inc.BiogenCompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, United Kingdom
-
BiogenElan PharmaceuticalsTerminated
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, Canada
-
Genentech, Inc.BiogenCompletedRheumatoid ArthritisUnited States, Puerto Rico
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsTerminatedLeukoencephalopathy, Progressive Multifocal | Immune Reconstitution Inflammatory SyndromeGermany, United States
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
BiogenElan PharmaceuticalsTerminatedProgressive Multifocal LeukoencephalopathyUnited States, Brazil, Italy, Spain, Germany
-
BiogenAcorda TherapeuticsCompleted
-
Kessler FoundationBiogenCompleted
-
UCB PharmaBiogenTerminatedMultiple SclerosisUnited States, France, Germany, Spain, Canada, Netherlands, Belgium, Hungary, Sweden, United Kingdom, Finland
-
Reata, a wholly owned subsidiary of BiogenTerminatedAutosomal Dominant Polycystic Kidney | ADPKDUnited States, Spain, United Kingdom, Australia, France, Japan, Germany, Belgium, Czechia, Italy
-
Reata, a wholly owned subsidiary of BiogenTerminatedConnective Tissue Disease-Associated Pulmonary Arterial HypertensionUnited States, Spain, Japan, Australia, United Kingdom, Canada, Germany, Belgium, Argentina, Israel, Mexico, Brazil, Czechia, Netherlands, Philippines
-
Reata, a wholly owned subsidiary of BiogenTerminatedPulmonary HypertensionUnited States, Spain, Australia, United Kingdom, Canada, Belgium, Argentina, Israel, Japan, Philippines, Germany, Mexico, Brazil, Czechia, Netherlands
-
Reata, a wholly owned subsidiary of BiogenCompletedFocal Segmental Glomerulosclerosis | IgA Nephropathy | Autosomal Dominant Polycystic Kidney | CKD Associated With Type 1 DiabetesUnited States